Breaking News
6 hours ago
Vaibhavi M.
Nxera Pharma secures Taiwan approval for QUVIVIQ insomnia drug via partner Holling Bio-Pharma, enabling 2026 launch and expanding access across Asian markets.
Vaibhavi M.
Avantor, Inc. secures exclusive distribution of Parafilm M in India from Amcor, expanding access to lab sealing solutions for contamination prevention and sample protection.
Vaibhavi M.
Praxis Precision Medicines secures FDA NDA acceptance for ulixacaltamide to treat essential tremor, with Phase 3 data supporting efficacy and PDUFA decision set for January 2027.
Vaibhavi M.
Amneal Pharmaceuticals launches generic albuterol and beclomethasone inhalers in the U.S. for asthma and bronchospasm, expanding its respiratory portfolio with complex MDI products.
Vaibhavi M.